Search Results - "LARGIS, E. E"

Refine Results
  1. 1
  2. 2

    Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines by Dolan, J A, Muenkel, H A, Burns, M G, Pellegrino, S M, Fraser, C M, Pietri, F, Strosberg, A D, Largis, E E, Dutia, M D, Bloom, J D

    “…The beta-1, beta-2 and beta-3 adrenergic properties of several benzodioxole-containing phenethanolamines were determined in vitro in both functional and…”
    Get more information
    Journal Article
  3. 3

    CL 277,082: a novel inhibitor of ACAT-catalyzed cholesterol esterification and cholesterol absorption by Largis, E E, Wang, C H, DeVries, V G, Schaffer, S A

    Published in Journal of lipid research (01-05-1989)
    “…CL 277,082 (I) was found to be a potent inhibitor of acyl CoA:cholesterol acyltransferase (ACAT, EC 2.3.1.26) in microsomes from a variety of tissues with IC50…”
    Get full text
    Journal Article
  4. 4

    Prodrugs of CL316243: a selective β3-adrenergic receptor agonist for treating obesity and diabetes by Sum, F.W., Gilbert, A., Venkatesan, A.M., Lim, K., Wong, V., O'Dell, M., Francisco, G., Chen, Z., Grosu, G., Baker, J., Ellingboe, J., Malamas, M., Gunawan, I., Primeau, J., Largis, E., Steiner, K.

    Published in Bioorganic & medicinal chemistry letters (01-07-1999)
    “…CL316243 is a highly selective and potent β 3-adrenergic receptor agonist, and has been shown in rodent models to be an effective agent for treating obesity…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Potential antiatherosclerotic agents. 6. Hypocholesterolemic trisubstituted urea analogs by DeVries, Vern G, Bloom, Jonathan D, Dutia, Minu D, Katocs, Andrew S, Largis, Elwood E

    Published in Journal of medicinal chemistry (01-10-1989)
    “…The discovery that a series of N,N-dialkyl-N'-arylureas were inhibitors of the ACAT enzyme has led to a structure-activity study involving the systematic…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Potential antiatherosclerotic agents. 2. (Aralkylamino)- and (alkylamino)benzoic acid analogs of cetaben by Albright, J. Donald, DeVries, Vern G, Largis, Elwood E, Miner, Thomas G, Reich, Marvin F, Schaffer, Sheldon A, Shepherd, Robert G, Upeslacis, Janis

    Published in Journal of medicinal chemistry (01-10-1983)
    “…The syntheses of a series of (aralkylamino)- and (alkylamino)benzoic acids, as well as the corresponding esters and sodium salts, are described. The compounds…”
    Get full text
    Journal Article
  11. 11

    Potential antiatherosclerotic agents. 4. [(Functionalized-alkyl)amino]benzoic acid analogs of cetaben by DeVries, Vern G, Largis, Elwood E, Miner, Thomas G, Shepherd, Robert G, Upeslacis, Janis

    Published in Journal of medicinal chemistry (01-10-1983)
    “…The synthesis of a series of analogues in which the alkyl group of cetaben is substituted with various functional groups or replaced entirely by a…”
    Get full text
    Journal Article
  12. 12

    Cyclic amine sulfonamides as linkers in the design and synthesis of novel human beta(3) adrenergic receptor agonists by Sum, Fuk Wah, Wong, Victoria, Han, Stella, Largis, Elwood, Mulvey, Ruth, Tillett, Jeff

    Published in Bioorganic & medicinal chemistry letters (07-07-2003)
    “…Piperidine, pyrrolidine, and azetidine sulfonamides were examined as linkers in designing novel human beta(3) adrenergic receptor (beta(3)-AR) agonists. The…”
    Get full text
    Journal Article
  13. 13

    Antilipolytic action of tolbutamide in isolated fat cells of the rat by Allen, D O, Largis, E E, Ashmore, J

    Published in Diabetes (New York, N.Y.) (01-01-1974)
    “…Concentrations of tolbutamide from 0.25 to 4.0 mg. per milliliter were found to inhibit epinephrine-stimulated lipolysis in isolated fat cells of the rat. At a…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Novel (4-piperidin-1-yl)-phenyl sulfonamides as potent and selective human beta(3) agonists by Hu, B, Ellingboe, J, Han, S, Largis, E, Lim, K, Malamas, M, Mulvey, R, Niu, C, Oliphant, A, Pelletier, J, Singanallore, T, Sum, F W, Tillett, J, Wong, V

    Published in Bioorganic & medicinal chemistry (01-08-2001)
    “…A series of novel (4-piperidin-1-yl)-phenyl sulfonamides was prepared and evaluated for their biological activity on the human beta(3)-adrenergic receptor…”
    Get full text
    Journal Article
  19. 19
  20. 20

    The effects of endothelial cell-conditioned media on the proliferation of aortic smooth muscle cells and 3T3 cells in culture by Wang, C H, Largis, E E, Schaffer, S A

    Published in Artery (1981)
    “…Normal aortic endothelial cells cultured in serum-free medium elaborate a factor(s) which cause the proliferation of smooth muscle cells or 3T3 cells grown in…”
    Get more information
    Journal Article